AB
SLRN

Amalgamated Bank’s ACELYRIN SLRN Stock Holding History

Amalgamated Bank’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,452
Closed -$6K – 3129
2025
Q1 		$6K Hold
2,452
– – ﹤0.01% 2619
2024
Q4 		$8K Hold
2,452
– – ﹤0.01% 2568
2024
Q3 		$12K Hold
2,452
– – ﹤0.01% 2371
2024
Q2 		$11K Hold
2,452
– – ﹤0.01% 2404
2024
Q1 		$17K Sell
2,452
-1,447
-37% -$11K ﹤0.01% 2210
2023
Q4 		$29K Sell
3,899
-382
-9% -$3.26K ﹤0.01% 2485
2023
Q3 		$44K Buy
+4,281
New +$90.9K ﹤0.01% 2310

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Amalgamated Bank's SLRN Position: Q2 2025 in Review

Amalgamated Bank sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 2,452 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $44K in Q3 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Amalgamated Bank reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 2,452 ACELYRIN shares in Q2 2025, an estimated $6K.
  • Amalgamated Bank first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
  • Amalgamated Bank's ACELYRIN position peaked at $44K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.